Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays

Mayo Clin Proc. 1993 Jul;68(7):657-64. doi: 10.1016/s0025-6196(12)60601-6.

Abstract

We have developed radioimmunoassays for the quantification of apolipoproteins (apo) C-I, C-II, and C-III in human plasma. The apo C proteins were isolated from very low-density lipoproteins of patients with hypertriglyceridemia, fractionated on a Sephacryl column, and purified by diethylaminoethyl cellulose anion-exchange chromatography followed by reverse-phase fast protein liquid chromatography. The assays were sensitive, specific, and reproducible, and the standards demonstrated parallel immunoreactivity with plasma samples. Patients with hypertriglyceridemia (triglyceride level more than 2,200 mg/liter)--14 patients with diabetes and 12 with type V hyperlipoproteinemia--were compared with age- and sex-matched control subjects. In comparison with the control groups, levels of apoproteins C-I, C-II, and C-III were significantly increased in both disease groups, but the ratios of the C peptides to triglycerides were significantly lower, an indication of a relative deficiency of C apoproteins in hypertriglyceridemic states. Independent radioimmunoassays for each of the C apolipoproteins would help to study their individual roles in triglyceride-rich lipoprotein metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Apolipoprotein C-I
  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Apolipoproteins C / blood*
  • Diabetes Mellitus / blood
  • Female
  • Humans
  • Hyperlipoproteinemia Type IV / blood
  • Hyperlipoproteinemia Type V / blood
  • Male
  • Middle Aged
  • Radioimmunoassay / methods
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Apolipoprotein C-I
  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Apolipoproteins C